nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Abnormal pigmentation—Epirubicin—bone cancer	0.0807	0.0848	CcSEcCtD
Propericiazine—Abnormal pigmentation—Doxorubicin—bone cancer	0.0746	0.0784	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—bone cancer	0.0335	0.0352	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—bone cancer	0.031	0.0326	CcSEcCtD
Propericiazine—Venous thromboembolism—Epirubicin—bone cancer	0.0259	0.0272	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—bone cancer	0.0239	0.0252	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—bone cancer	0.0228	0.0239	CcSEcCtD
Propericiazine—Pigmentation disorder—Doxorubicin—bone cancer	0.0211	0.0222	CcSEcCtD
Propericiazine—Infection—Carboplatin—bone cancer	0.0179	0.0188	CcSEcCtD
Propericiazine—Liver injury—Cisplatin—bone cancer	0.0176	0.0185	CcSEcCtD
Propericiazine—Sudden death—Methotrexate—bone cancer	0.0159	0.0167	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—bone cancer	0.0151	0.0158	CcSEcCtD
Propericiazine—Body temperature increased—Carboplatin—bone cancer	0.0142	0.015	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—bone cancer	0.0139	0.0147	CcSEcCtD
Propericiazine—Deep vein thrombosis—Methotrexate—bone cancer	0.0134	0.014	CcSEcCtD
Propericiazine—Nasal congestion—Cisplatin—bone cancer	0.0118	0.0124	CcSEcCtD
Propericiazine—Hypokalaemia—Cisplatin—bone cancer	0.00978	0.0103	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—bone cancer	0.00978	0.202	CrCbGaD
Propericiazine—Sweating increased—Cisplatin—bone cancer	0.00905	0.00951	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—bone cancer	0.00904	0.0095	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—bone cancer	0.00865	0.0091	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—bone cancer	0.00865	0.0091	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—bone cancer	0.00836	0.00879	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—bone cancer	0.00813	0.00854	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—bone cancer	0.00809	0.0085	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—bone cancer	0.00801	0.00842	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—bone cancer	0.00801	0.00842	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—bone cancer	0.00784	0.00824	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—bone cancer	0.00761	0.00799	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—bone cancer	0.00761	0.00799	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—bone cancer	0.00749	0.00787	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—bone cancer	0.00727	0.00764	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—bone cancer	0.00725	0.00762	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—bone cancer	0.00704	0.0074	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—bone cancer	0.00704	0.0074	CcSEcCtD
Propericiazine—Cardiac disorder—Cisplatin—bone cancer	0.0069	0.00725	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—bone cancer	0.00672	0.00706	CcSEcCtD
Propericiazine—Arrhythmia—Cisplatin—bone cancer	0.00664	0.00698	CcSEcCtD
Propericiazine—Alimemazine—CYP3A4—bone cancer	0.00652	0.135	CrCbGaD
Propericiazine—Photosensitivity—Epirubicin—bone cancer	0.00629	0.00661	CcSEcCtD
Propericiazine—Vision blurred—Cisplatin—bone cancer	0.0061	0.00641	CcSEcCtD
Propericiazine—Tremor—Cisplatin—bone cancer	0.00607	0.00637	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—bone cancer	0.00588	0.00617	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—bone cancer	0.00582	0.00611	CcSEcCtD
Propericiazine—Mequitazine—CYP3A4—bone cancer	0.00562	0.116	CrCbGaD
Propericiazine—Domperidone—CYP3A4—bone cancer	0.00555	0.114	CrCbGaD
Propericiazine—Increased appetite—Doxorubicin—bone cancer	0.00544	0.00571	CcSEcCtD
Propericiazine—Oedema—Cisplatin—bone cancer	0.00528	0.00555	CcSEcCtD
Propericiazine—Infection—Cisplatin—bone cancer	0.00525	0.00552	CcSEcCtD
Propericiazine—Tachycardia—Cisplatin—bone cancer	0.00516	0.00542	CcSEcCtD
Propericiazine—Hyperhidrosis—Cisplatin—bone cancer	0.00511	0.00537	CcSEcCtD
Propericiazine—Asthma—Methotrexate—bone cancer	0.0051	0.00536	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—bone cancer	0.00505	0.0053	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—bone cancer	0.00502	0.00528	CcSEcCtD
Propericiazine—Hypotension—Cisplatin—bone cancer	0.00494	0.00519	CcSEcCtD
Propericiazine—Asthma—Epirubicin—bone cancer	0.00477	0.00501	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—bone cancer	0.00472	0.00496	CcSEcCtD
Propericiazine—Dyspnoea—Cisplatin—bone cancer	0.00471	0.00495	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—bone cancer	0.0047	0.00493	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—bone cancer	0.00465	0.00489	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—bone cancer	0.00465	0.00489	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—bone cancer	0.00457	0.00481	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—bone cancer	0.00455	0.00478	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—bone cancer	0.00441	0.00464	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—bone cancer	0.00437	0.00459	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—bone cancer	0.00435	0.00458	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—bone cancer	0.00434	0.00456	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—bone cancer	0.0043	0.00452	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—bone cancer	0.00428	0.0045	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—bone cancer	0.00425	0.00447	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—bone cancer	0.00424	0.00446	CcSEcCtD
Propericiazine—Body temperature increased—Cisplatin—bone cancer	0.00418	0.00439	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—bone cancer	0.00415	0.00436	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00403	0.00423	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—bone cancer	0.00402	0.00422	CcSEcCtD
Propericiazine—Pipotiazine—CYP3A4—bone cancer	0.00399	0.0824	CrCbGaD
Propericiazine—Hyperglycaemia—Doxorubicin—bone cancer	0.00398	0.00419	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—bone cancer	0.00397	0.00417	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—bone cancer	0.00396	0.00416	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—bone cancer	0.00394	0.00414	CcSEcCtD
Propericiazine—Hypersensitivity—Cisplatin—bone cancer	0.00389	0.00409	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—bone cancer	0.00384	0.00403	CcSEcCtD
Propericiazine—Prochlorperazine—CYP3A4—bone cancer	0.00382	0.0788	CrCbGaD
Propericiazine—Cardiac disorder—Methotrexate—bone cancer	0.00379	0.00398	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—bone cancer	0.00367	0.00386	CcSEcCtD
Propericiazine—Diarrhoea—Cisplatin—bone cancer	0.00361	0.0038	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—bone cancer	0.00354	0.00372	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—bone cancer	0.00341	0.00359	CcSEcCtD
Propericiazine—Vomiting—Cisplatin—bone cancer	0.00336	0.00353	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—bone cancer	0.00335	0.00352	CcSEcCtD
Propericiazine—Rash—Cisplatin—bone cancer	0.00333	0.0035	CcSEcCtD
Propericiazine—Dermatitis—Cisplatin—bone cancer	0.00333	0.0035	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—bone cancer	0.00328	0.00345	CcSEcCtD
Propericiazine—Clomipramine—CYP3A4—bone cancer	0.00316	0.0652	CrCbGaD
Propericiazine—Arrhythmia—Doxorubicin—bone cancer	0.00316	0.00332	CcSEcCtD
Propericiazine—Nausea—Cisplatin—bone cancer	0.00314	0.0033	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—bone cancer	0.00313	0.00329	CcSEcCtD
Propericiazine—Agitation—Epirubicin—bone cancer	0.00306	0.00321	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—bone cancer	0.00292	0.00307	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—bone cancer	0.0029	0.00305	CcSEcCtD
Propericiazine—Infection—Methotrexate—bone cancer	0.00288	0.00303	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—bone cancer	0.00283	0.00297	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—bone cancer	0.0028	0.00295	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—bone cancer	0.00277	0.00291	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—bone cancer	0.00274	0.00288	CcSEcCtD
Propericiazine—Perphenazine—CYP3A4—bone cancer	0.00273	0.0563	CrCbGaD
Propericiazine—Oedema—Epirubicin—bone cancer	0.00271	0.00285	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—bone cancer	0.00271	0.00285	CcSEcCtD
Propericiazine—Infection—Epirubicin—bone cancer	0.0027	0.00283	CcSEcCtD
Propericiazine—Quetiapine—CYP3A4—bone cancer	0.00268	0.0552	CrCbGaD
Propericiazine—Tachycardia—Epirubicin—bone cancer	0.00265	0.00278	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—bone cancer	0.00262	0.00276	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—bone cancer	0.00262	0.00276	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—bone cancer	0.00258	0.00272	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—bone cancer	0.00258	0.00271	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—bone cancer	0.00256	0.00269	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—bone cancer	0.00254	0.00266	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—bone cancer	0.00253	0.00266	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—bone cancer	0.00251	0.00264	CcSEcCtD
Propericiazine—Infection—Doxorubicin—bone cancer	0.00249	0.00262	CcSEcCtD
Propericiazine—Promazine—CYP3A4—bone cancer	0.00246	0.0508	CrCbGaD
Propericiazine—Insomnia—Epirubicin—bone cancer	0.00245	0.00258	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—bone cancer	0.00245	0.00257	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—bone cancer	0.00243	0.00255	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—bone cancer	0.00242	0.00254	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—bone cancer	0.00241	0.00253	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—bone cancer	0.00235	0.00247	CcSEcCtD
Propericiazine—Constipation—Epirubicin—bone cancer	0.00232	0.00244	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—bone cancer	0.00229	0.00241	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—bone cancer	0.00227	0.00239	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—bone cancer	0.00224	0.00235	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—bone cancer	0.00223	0.00235	CcSEcCtD
Propericiazine—Chlorpromazine—CYP3A4—bone cancer	0.00217	0.0447	CrCbGaD
Propericiazine—Constipation—Doxorubicin—bone cancer	0.00215	0.00226	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—bone cancer	0.00214	0.00225	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—bone cancer	0.00214	0.00224	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—bone cancer	0.002	0.0021	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—bone cancer	0.00198	0.00209	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—bone cancer	0.00198	0.00208	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—bone cancer	0.00186	0.00195	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—bone cancer	0.00185	0.00194	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—bone cancer	0.00184	0.00194	CcSEcCtD
Propericiazine—Rash—Methotrexate—bone cancer	0.00183	0.00192	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—bone cancer	0.00183	0.00192	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—bone cancer	0.00173	0.00181	CcSEcCtD
Propericiazine—Nausea—Methotrexate—bone cancer	0.00172	0.00181	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—bone cancer	0.00172	0.00181	CcSEcCtD
Propericiazine—Rash—Epirubicin—bone cancer	0.00171	0.0018	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—bone cancer	0.00171	0.0018	CcSEcCtD
Propericiazine—Nausea—Epirubicin—bone cancer	0.00161	0.00169	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—bone cancer	0.0016	0.00168	CcSEcCtD
Propericiazine—Rash—Doxorubicin—bone cancer	0.00158	0.00166	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—bone cancer	0.00158	0.00166	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—bone cancer	0.00149	0.00157	CcSEcCtD
